Crispr Therapeutics shares owned by Reynders McVeigh Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Reynders McVeigh Capital Management
from 13F filings
Historical chart of Reynders McVeigh Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Reynders McVeigh Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Reynders McVeigh Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.6M | 120k | 46.98 |
| 2024-06-30 | $6.2M | 115k | 54.01 |
| 2024-03-31 | $6.6M | 97k | 68.17 |
| 2023-12-31 | $5.8M | 92k | 62.60 |
| 2023-09-30 | $3.5M | 76k | 45.39 |
| 2023-06-30 | $2.8M | 50k | 56.14 |
| 2023-03-31 | $855k | 19k | 45.23 |
| 2022-09-30 | $202k | 3.1k | 65.48 |
| 2022-03-31 | $294k | 4.7k | 62.82 |
| 2021-12-31 | $217k | 2.9k | 75.74 |
| 2021-09-30 | $302k | 2.7k | 111.85 |
| 2021-06-30 | $422k | 2.6k | 162.00 |
| 2021-03-31 | $300k | 2.5k | 121.95 |
| 2020-12-31 | $374k | 2.4k | 153.28 |
| 2020-09-30 | $208k | 2.5k | 83.53 |
More positions owned by Reynders McVeigh Capital Management
View all positions for Reynders McVeigh Capital Management